Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use IDVYNSO safely and effectively. See full prescribing information for IDVYNSO. IDVYNSO™ (doravirine and islatravir) tablets, for oral useInitial U.S. Approval: 2026
Medication labelWhy this: Advisory · dailymed-prescription
IDVYNSO™ is indicated as a complete two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen with no history of virologic treatment failure and no known substitutions associated with resistance to doravirine [see Microbiology (12.4) and Clinical Studies (14)].
- generic_name
- doravirine, islatravir
- product_names
- Doravirine, Islatravir
- ndc
- 0006-5092, 0006-5092-01, 0006-5092-59
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en